Investing News Network on MSN

Moderna to pay US$950 million to settle COVID-19 vaccine patent dispute

Moderna (NASDAQ:MRNA) has agreed to pay US$950 million to resolve a long-running patent dispute tied to the technology used ...

Moderna’s stock rallies as settlement of a patent dispute clears vaccine pipeline

The deal would provide ‘certainty’ for Moderna’s vaccine portfolio.

Moderna to pay up to $2.25B to end mRNA vaccine patent fight

Announced days before a trial, the deal settles a longstanding dispute and avoids what one analyst called a “worst-case ...

Moderna reaches vaccine settlement, GitLab's guidance disappoints

Yahoo Finance anchor Josh Lipton tracks today's top moving stocks and biggest market stories in this Market Minute. US stock ...

Shares jump as Moderna settles Covid vaccine dispute

Shares in Moderna sparked on Wednesday, after the US drugs firm settled a long-running legal dispute concerning its Covid-19 ...

Reddit Traders Are Cheering Moderna While Bears Watch the Cash Burn

Investors who closely watch the healthcare sector are keeping an eye on Moderna (NASDAQ:MRNA) as its shares are up 12% over ...
News Tribune

Moderna Receives European Commission Marketing Authorization for COVID-19 Vaccine mNEXSPIKE

mNEXSPIKE is the third Moderna vaccine authorized in the European Union, strengthening the Company's respiratory vaccine portfolio in Europe CAMBRIDGE, MA / ACCESS Newswire / February 17, 2026 / ...